Randomized, open, controlled phase II clinical study of apatinib piece (AiTan) combined the Sox scheme first-line treatment of advanced gastric cancer under the background of panoramic cancer gene detection.

Trial Profile

Randomized, open, controlled phase II clinical study of apatinib piece (AiTan) combined the Sox scheme first-line treatment of advanced gastric cancer under the background of panoramic cancer gene detection.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2017

At a glance

  • Drugs Apatinib (Primary) ; Gimeracil; Oteracil; Oxaliplatin; Tegafur
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top